Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 4382-4386, October 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raught, B.
Right arrow Articles by Rosen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raught, B.
Right arrow Articles by Rosen, J. M.

Expression of a Translationally Regulated, Dominant-Negative CCAAT/Enhancer-binding Protein ß Isoform and Up-Regulation of the Eukaryotic Translation Initiation Factor 2{alpha} Are Correlated with Neoplastic Transformation of Mammary Epithelial Cells1

Brian Raught, Anne-Claude Gingras, Alaina James, Daniel Medina, Nahum Sonenberg and Jeffrey M. Rosen2

Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030-3498 [B. R., A. J., D. M., J. M. R.], and Department of Biochemistry and McGill Cancer Center, Faculty of Medicine, McGill University, Montreal, Quebec H3G 1Y6, Canada [A-C. G., N. S.]

A translationally regulated, dominant-negative isoform of CCAAT/enhancer-binding protein ß is expressed in transplantable and primary mouse mammary tumors of different etiologies but is not expressed in preneoplastic mammary hyperplasias or in primary prostate, lung, lens, ovary, or lymphoid tumors. The eukaryotic initiation factor 2{alpha} protein is also expressed at significantly higher levels (69.8 ± 7.2%) in these mammary tumors compared with normal and hyperplastic tissues. Thus, misregulation of eukaryotic initiation factor 2{alpha} may promote the expression of a dominant-negative CCAAT/enhancer-binding protein ß isoform, which may inhibit terminal differentiation and facilitate uncontrolled proliferation of mammary epithelial cells.

1 This work was supported by NIH Grants CA-47112 (D. M.), CA-16303 (J. M. R.), and DK-07696 (B. R.).

2 To whom requests for reprints should be addressed, at Department of Cell Biology, Texas Medical Center, Baylor College of Medicine, Houston, TX 77030-3498. E-mail: jrosen@bcm.tmc.edu.

Received 7/19/96. Accepted 8/16/96.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
A. Plachetka, O. Chayka, C. Wilczek, S. Melnik, C. Bonifer, and K.-H. Klempnauer
C/EBP{beta} Induces Chromatin Opening at a Cell-Type-Specific Enhancer
Mol. Cell. Biol., March 15, 2008; 28(6): 2102 - 2112.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. V. Arcidiacono, T. Sato, D. Alvarez-Hernandez, J. Yang, M. Tokumoto, I. Gonzalez-Suarez, Y. Lu, Y. Tominaga, J. Cannata-Andia, E. Slatopolsky, et al.
EGFR Activation Increases Parathyroid Hyperplasia and Calcitriol Resistance in Kidney Disease
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 310 - 320.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhang, X. Pan, and J. W. B. Hershey
Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells
J. Biol. Chem., February 23, 2007; 282(8): 5790 - 5800.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Jankiewicz, B. Groner, and S. Desrivieres
Mammalian Target of Rapamycin Regulates the Growth of Mammary Epithelial Cells through the Inhibitor of Deoxyribonucleic Acid Binding Id1 and Their Functional Differentiation through Id2
Mol. Endocrinol., October 1, 2006; 20(10): 2369 - 2381.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Quintanilla-Martinez, S. Pittaluga, C. Miething, M. Klier, M. Rudelius, T. Davies-Hill, N. Anastasov, A. Martinez, A. Vivero, J. Duyster, et al.
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma
Blood, September 15, 2006; 108(6): 2029 - 2036.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Jundt, N. Raetzel, C. Muller, C. F. Calkhoven, K. Kley, S. Mathas, A. Lietz, A. Leutz, and B. Dorken
A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas
Blood, September 1, 2005; 106(5): 1801 - 1807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. A. Timchenko, G.-L. Wang, and L. T. Timchenko
RNA CUG-binding Protein 1 Increases Translation of 20-kDa Isoform of CCAAT/Enhancer-binding Protein {beta} by Interacting with the {alpha} and {beta} Subunits of Eukaryotic Initiation Translation Factor 2
J. Biol. Chem., May 27, 2005; 280(21): 20549 - 20557.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. T. Tilli, R. Reiter, A. S. Oh, R. T. Henke, K. McDonnell, G. I. Gallicano, P. A. Furth, and A. T. Riegel
Overexpression of an N-Terminally Truncated Isoform of the Nuclear Receptor Coactivator Amplified in Breast Cancer 1 Leads to Altered Proliferation of Mammary Epithelial Cells in Transgenic Mice
Mol. Endocrinol., March 1, 2005; 19(3): 644 - 656.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. R. Baldwin, N. A. Timchenko, and C. A. Zahnow
Epidermal Growth Factor Receptor Stimulation Activates the RNA Binding Protein CUG-BP1 and Increases Expression of C/EBP{beta}-LIP in Mammary Epithelial Cells
Mol. Cell. Biol., May 1, 2004; 24(9): 3682 - 3691.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. T. Timchenko, P. Iakova, A. L. Welm, Z.-J. Cai, and N. A. Timchenko
Calreticulin Interacts with C/EBP{alpha} and C/EBP{beta} mRNAs and Represses Translation of C/EBP Proteins
Mol. Cell. Biol., October 15, 2002; 22(20): 7242 - 7257.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. I. Chen, K. M. Sommer, and K. Swisshelm
Downstream Codons in the Retinoic Acid Receptor beta -2 and beta -4 mRNAs Initiate Translation of a Protein Isoform That Disrupts Retinoid-activated Transcription
J. Biol. Chem., September 13, 2002; 277(38): 35411 - 35421.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. HARVEY, Y. ZHANG, F. LANDRY, C. MILLER, and J. W. SMITH
Insights into a plasma membrane signature
Physiol Genomics, April 2, 2001; 5(3): 129 - 136.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A.-C. Gingras, B. Raught, and N. Sonenberg
Regulation of translation initiation by FRAP/mTOR
Genes & Dev., April 1, 2001; 15(7): 807 - 826.
[Full Text]


Home page
Cancer Res.Home page
C. A. Zahnow, R. D. Cardiff, R. Laucirica, D. Medina, and J. M. Rosen
A Role for CCAAT/Enhancer Binding Protein {beta}-Liver-enriched Inhibitory Protein in Mammary Epithelial Cell Proliferation
Cancer Res., January 1, 2001; 61(1): 261 - 269.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
C. F. Calkhoven, C. Müller, and A. Leutz
Translational control of C/EBPalpha and C/EBPbeta isoform expression
Genes & Dev., August 1, 2000; 14(15): 1920 - 1932.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
S. S. Palakurthi, R. Fluckiger, H. Aktas, A. K. Changolkar, A. Shahsafaei, S. Harneit, E. Kilic, and J. A. Halperin
Inhibition of Translation Initiation Mediates the Anticancer Effect of the n-3 Polyunsaturated Fatty Acid Eicosapentaenoic Acid
Cancer Res., June 1, 2000; 60(11): 2919 - 2925.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. N. Seagroves, J. P. Lydon, R. C. Hovey, B. K. Vonderhaar, and J. M. Rosen
C/EBP{beta} (CCAAT/Enhancer Binding Protein) Controls Cell Fate Determination during Mammary Gland Development
Mol. Endocrinol., March 1, 2000; 14(3): 359 - 368.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
A. L. Welm, N. A. Timchenko, and G. J. Darlington
C/EBPalpha Regulates Generation of C/EBPbeta Isoforms through Activation of Specific Proteolytic Cleavage
Mol. Cell. Biol., March 1, 1999; 19(3): 1695 - 1704.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. W. Robinson, P. F. Johnson, L. Hennighausen, and E. Sterneck
The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland
Genes & Dev., June 15, 1998; 12(12): 1907 - 1916.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
T. N. Seagroves, S. Krnacik, B. Raught, J. Gay, B. Burgess-Beusse, G. J. Darlington, and J. M. Rosen
C/EBPbeta , but not C/EBPalpha , is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland
Genes & Dev., June 15, 1998; 12(12): 1917 - 1928.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Baer and P. F. Johnson
Generation of Truncated C/EBPbeta Isoforms by in Vitro Proteolysis
J. Biol. Chem., August 18, 2000; 275(34): 26582 - 26590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-M. Hu, Q. Tian, M. Baer, C. J. Spooner, S. C. Williams, P. F. Johnson, and R. C. Schwartz
The C/EBP bZIP Domain Can Mediate Lipopolysaccharide Induction of the Proinflammatory Cytokines Interleukin-6 and Monocyte Chemoattractant Protein-1
J. Biol. Chem., May 19, 2000; 275(21): 16373 - 16381.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.